Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/1995
11/09/1995CA2189013A1 Binding of e-selectin, p-selectin or l-selectin to sialyl-lewisx or sialyl-lewisa
11/08/1995EP0680962A2 Heterocyclic compounds
11/08/1995EP0680752A2 Conditioned water soluble substances
11/08/1995EP0680488A1 2,6-diaminopurine derivatives
11/08/1995EP0680337A1 Methods and compositions for the direct concentrated delivery of passive immunity
11/07/1995US5464935 Peptide inhibitors of selectin binding
11/07/1995US5464844 [3H,7H]thiazole[3,4-a]pyridines having antiasthmatic and antiinflammatory activities on the respiratory tract
11/07/1995US5464838 Aminocarboxylic acid derivatives having antiallergic/antiasthmatic effect and a process for their preparation
11/07/1995US5464822 Polypeptides and polypeptide analogues
11/07/1995US5464817 Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
11/02/1995WO1995028931A1 Spiro-substituted azacycles as neurokinin-3 antagonists
11/02/1995EP0679630A1 Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses
11/02/1995EP0679182A1 Delivery of gene products via mesangial cells
11/02/1995CA2188031A1 Spiro-substituted azacycles as neurokinin-3 antagonists
10/1995
10/31/1995US5463087 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments
10/31/1995US5463083 2,5-diaryl tetrahydrothiophenes, tetrahydrofurans and 1,3-diaryl-cyclopentanes which act as platelet activating factor receptor antagonists and/or inhibitors of the enzyme 5-lipoxygenase
10/31/1995US5462959 4-aryl-imidazole derivatives
10/31/1995US5462946 Metal-independent nitroxide or oxazolidine-1-oxyl forming compound in biologically acceptable carrier to protect biological material from oxidative stress
10/29/1995CA2147925A1 Pseudopeptides derived from neurokinins; process for preparing the same and pharmaceutical compositions containing them
10/26/1995WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220
10/26/1995WO1995028418A2 Tachykinin antagonists
10/26/1995WO1995028406A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
10/26/1995WO1995028170A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995CA2188287A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995CA2183991A1 Tachykinin antagonists
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995CN1110587A Lycopodium clavatum injection and its preparation method
10/25/1995CN1110580A Anti-virus and antipyretic oral liquid
10/24/1995US5461061 Antidepressants
10/24/1995US5461059 Derivatives of terbutylphenyl-1-amino-4-hydroxybutane their preparation processes and the pharmaceutical compositions containing them
10/24/1995US5460829 Fine particle size
10/19/1995WO1995027723A1 Receptor modulating agents and methods relating thereto
10/19/1995WO1995027706A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
10/19/1995WO1995027496A1 Vasoactive intestinal polypeptide
10/19/1995WO1995027490A1 Use of serotonin antagonists (5ht3) for treating fibromyalgia
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/19/1995CA2187322A1 Vasoactive intestinal polypeptide
10/18/1995EP0677524A1 Thieno[3,2-F][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives as PAF antagonists
10/18/1995EP0677290A1 Percutaneous preparation comprising tulobuterol
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677059A1 Endothelin converting enzyme inhibitors
10/18/1995CN1110154A Sugar-free sarcandra glabra lozenge
10/17/1995US5459156 Angiotensin converting enzyme inhibitors, hypotensive, atherosclerosis
10/17/1995US5459152 Platelet activating factor antagonists
10/17/1995US5459151 N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995027052A1 Human interleukin variants generated by alternative splicing
10/12/1995WO1995026957A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
10/12/1995WO1995026768A1 Methods for treating pulmonary vasoconstriction and asthma
10/12/1995WO1995026727A1 Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them
10/12/1995WO1995026716A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
10/12/1995DE4411660A1 Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung The use of xanthine derivatives for reducing the pathological hyperreactivity eosinophilic granulocytes, new xanthine compounds and processes for their preparation
10/12/1995CA2187081A1 Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them
10/12/1995CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity
10/12/1995CA2186854A1 Human interleukin variants generated by alternative splicing
10/11/1995EP0676396A1 Tetrazolylphenyl pivalate derivatives and medicinal composition containing the same as effective component
10/11/1995EP0676395A2 Substituted N-heteroaroylguanidines, as inhibitors of sodium-hydrogen exchange, as antiarrhythmic agents and as inhibitors of the proliferation of cells
10/11/1995EP0675902A1 Endothelin antagonists
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0474817B1 Bicyclo [3.3.0]octane derivatives, process for producing them and their pharmaceutical use
10/11/1995CN1110057A Tricyclic defem sulphones as elastase inhibitors
10/11/1995CN1109753A Methods of inhibiting pulmonary hypertensive diseases
10/11/1995CN1029972C Selective adenosine receptor compounds
10/11/1995CN1029967C New xanthine derivatives
10/10/1995US5457212 Resolution of a thienopyran derivative using methylbenzyl isocyanate; nitration
10/10/1995US5457124 Antiinflammatory agent
10/10/1995US5457090 A serine proteolytic enzyme inhibitor
10/10/1995CA1337297C Aminoacylates of glycerol acetal
10/05/1995WO1995026360A1 Antagonists of endothelin receptors
10/05/1995WO1995026346A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
10/05/1995WO1995026197A1 Adhesion inhibiting composition
10/05/1995DE4411225A1 Verwendung von Carbonsäurederivaten als Arzneimittel The use of carboxylic acid derivatives as medicaments
10/05/1995CA2186377A1 Adhesion inhibiting composition
10/05/1995CA2183767A1 Antagonists of endothelin receptors
10/04/1995EP0675120A2 Use of ascorbyl-gamma-linolenate or a ascorbyl-dihomo-gamma-linolenate for the treatment of asthma, cancer, cardiovascular and inflammatory disorders
10/04/1995EP0675110A1 1H-Indole-3-glyoxylamide sPLA2 inhibitors
10/04/1995EP0674705A1 Antisense oligonucleotides to inhibit expression of mutated and wild type genes for collagen
10/04/1995EP0674633A1 Benzopyran derivatives
10/04/1995EP0674632A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors
10/03/1995US5455337 Treatment of asthma, helminth infections
10/03/1995US5455274 Leukotriene antagonists; treating rheumatoid arthritis
10/03/1995US5455252 Optionally substituted 6,8-quinolines
10/03/1995US5455227 Biologically active lipoprotein and its use
10/03/1995US5455226 Administering epidermal growth factor to stimulate repair of respiratory epithelial wounds
09/1995
09/28/1995WO1995025800A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS
09/28/1995WO1995025718A1 Vitamin-d amide derivatives
09/28/1995CA2186242A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995CA2185813A1 Vitamin-d amide derivatives
09/27/1995EP0673938A2 Novel purine derivatives and pharmaceutically acceptable salts thereof
09/27/1995EP0673932A1 Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-N-oxides, process for their preparation and their use as medicaments
09/27/1995EP0673928A1 Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists
09/27/1995EP0673646A2 Use of Deoxypergualin in the manufacture of a medicament for the treatment of inflammatory-hyperresponsiveness diseases
09/27/1995EP0673426A1 Platelet-activating factor acetylhydrolase
09/27/1995EP0673367A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists
09/27/1995EP0673240A1 Stabilized medicinal aerosol solution formulations
09/27/1995EP0616525B1 Pharmaceutical aerosol formulation
09/27/1995EP0549621B1 New leukotriene-b4 antagonists, process for producing the same and their use as medicinal drugs
09/27/1995EP0529022B1 New leukotriene b 4? derivatives, method for preparing them and their use as drugs
09/27/1995EP0526535B1 Cyclic hydroxamic acids and their use
1 ... 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 ... 878